JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goyagi, T.
Right arrow Articles by Kirsch, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goyagi, T.
Right arrow Articles by Kirsch, J. R.
Related Collections
Right arrow Neuroanesthesia
Right arrow Pharmacology

Anesth Analg 2003;96:532-538
© 2003 International Anesthesia Research Society

NEUROSURGICAL ANESTHESIA

Potent {sigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Provides Ischemic Neuroprotection Without Altering Dopamine Accumulation In Vivo in Rats

Toru Goyagi, MD*, Anish Bhardwaj, MD*,{dagger}, Raymond C. Koehler, PhD*, Richard J. Traystman, PhD*, Patricia D. Hurn, PhD*, and Jeffrey R. Kirsch, MD*,{dagger}

Departments of *Anesthesiology and Critical Care Medicine and {dagger}Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Address correspondence and reprint requests to Anish Bhardwaj, MD, Neurosciences Critical Care Division, Meyer 8–140, Johns Hopkins Hospital, 600 N Wolfe St., Baltimore, MD 21287. Address e-mail to abhardwa{at}jhmi.edu

The in vivo signaling of ischemic neuroprotection provided by {varsigma}-receptor ligands remains unclear. Catecholamines have been implicated in the propagation of ischemic neuronal injury, and previous in vitro studies suggest that {varsigma} ligands modulate dopaminergic neurotransmission. In this study, we tested the hypothesis that the potent {varsigma}1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) attenuates the increase of extracellular dopamine in ischemic striatum. Under controlled physiological conditions, a microdialysis probe was implanted in right caudoputamen (CP) complex of adult male Wistar rats. Rats were subjected to 2 h of transient middle cerebral artery occlusion (MCAO) by the intraluminal suture technique. In a blinded, randomized fashion, rats were divided into five treatment groups: Group 1 (n = 8; saline-saline) continuous IV infusion of saline vehicle 30 min before MCAO followed by saline at reperfusion until the end of the experiment; Group 2 (n = 8; PPBP-PPBP) IV PPBP 30 min before MCAO followed by 1 µmol · kg-1 · h-1 of PPBP; Group 3 (n = 8; saline-PPBP) IV saline before MCAO followed by PPBP; Group 4 (n = 4) surgical shams (saline-saline); and Group 5 (n = 4) surgical shams (PPBP-PPBP). Infarction volume at 22 h of reperfusion in the CP complex (percentage of ipsilateral structure) was significantly attenuated in rats treated with PPBP-PPBP (27.3% ± 9.1%) and saline-PPBP (27.8% ± 12.7%) compared with saline-saline (59.3% ± 7.3%) treatment. There was a three- to fourfold increase in dopamine concentrations in the microdialysates within 40 min of the onset of MCAO. Dopamine and its metabolites dihydroxy phenylacetic acid and homovallinic acid levels were similar among the three groups subjected to MCAO. Therefore, PPBP provides significant ischemic neuroprotection in the CP complex without altering the acute accumulation of dopamine in vivo during transient focal ischemia in the rat.

IMPLICATIONS: {varsigma}1-Receptor ligands decrease infarction size in the striatum when given before or after onset of stroke without affecting ischemia-evoked dopamine efflux.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
S. Yang, A. Bhardwaj, J. Cheng, N. J. Alkayed, P. D. Hurn, and J. R. Kirsch
Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2
Anesth. Analg., May 1, 2007; 104(5): 1179 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T.-Y. Chen, T. Goyagi, T. J.K. Toung, J. R. Kirsch, P. D. Hurn, R. C. Koehler, and A. Bhardwaj
Prolonged Opportunity for Ischemic Neuroprotection with Selective {kappa}-Opioid Receptor Agonist in Rats
Stroke, May 1, 2004; 35(5): 1180 - 1185.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.